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The existence of multiple isotypes of T  cell receptors has been hypothesized (1, 2). 
A  biological role for individual isotypes could be linked to the effector function of 
their constant regions. A cytotoxic T cell may effectively use a different molecule than 
does  a  suppressor  T  cell.  Alternatively,  T  cell  isotypes  may  be  characteristically 
distributed on cells at different stages in immune competence, i.e., a  pre-T cell may 
use  a  different  isotype  than  an  antigen-triggered  effector cell.  The  experiments 
described here use monoclonal antibodies, specific for products of the IgT-C region of 
chromosome 12 (G. M. Spurll, M. Frye, L. Riendeau, A. Finnegan, and F. L. Owen, 
manuscript in preparation), to address the later question. 
Three T  cell alloantigens linked  to Igh-1,  but  separable  by recombination from 
these genes, have been described (2, 3). These antigens may be allotypic determinants 
in the constant regions of antigen-specific receptors (1-5). Tthy  d, Tind  d, and Tsu  d are 
expressed  preferentially on  thymocytes or  Lyt  2  +  peripheral  cells  or  Lyt-1  +  cells, 
respectively. In this study, cells at different stages in immunological maturation were 
examined by cytotoxicity for expression of these three antigens. The order of appear- 
ance from the marrow to the antigen-triggered cell is Tthy  d, Tind  d,  or Tsu  d.  This 
parallels the order of appearance of these antigens in ontogeny. Tthy  d is a thymocyte 
surface marker at days 1-2 after birth, Tind  d is detectable at days 2-3 after birth, and 
Tsu  d appears at days 5-6 after birth. 
These studies illustrate a maturational sequence for the appearance of Tthy, Tind, 
and Tsu but are also consistent with some functional compartmentalization of the 
receptor repertoire because  none  of these  alloantigens  are  present  on  cytotoxic or 
mixed  leukocyte-reactive (MLR) 1 cells  (G.  M.  Spurll  et  al.,  see  above).  It  seems 
probable  that  acquisition  of isotypes  is  not  the  biological  pressure  for  functional 
differentiation because  all  these  antigens  are  acquired  postnatally,  and  functional 
preT cells are already present in embryonic thymus (6). 
These studies show that  Tthy, Tind, and  Tsu segregate independently in T  cell 
hybrids, demonstrating that they are products of separate genes and not individual 
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allotypic determinants on the same polypeptide. However, some hybrids (15%)  show 
Tthy  d coexpression with Tind  d or Tsu  d. This stable dual expression is reminescent of 
the  B  cell  that  expresses  both  IgM  and  IgD  (7).  The  data  are  consistent with  a 
maturational model for T  cells in which Tthy  d antigen is expressed on a precursor cell 
for the antigen-triggered cells bearing Tsu  d and Tindd; evidence for Tsu and Tind 
being separate lineages of cells is presented. Although the Tthyd-bearing cell may be 
a  precursor for the Tind  d and Tsud-bearing cells, it is not a  pre-T cell (8, 9). 
Materials and Methods 
Mice.  C.AL-20  mice,  bred  at  Tufts  Medical  School  since  1978, originated from  stock 
developed by M. Potter, National Institutes of Health, Bethesda, MD. A/J and AKR nude 
streaker mice (nu/nu  and age-matched nu/+)  were purchased from The Jackson Laboratory, 
Bar  Harbor,  ME.  BALB/c  AnN  animals were  purchased  from  Charles  River  Breeding 
Laboratories, Inc., Wilmington, MA. 
Production of Monoclonal Cell Lines.  Clones of cells producing monoclonal antibodies directed 
against T  cell products were selected  by fusion of BALB/c anti-C.AL-20-immune  spleen cells 
with the BALB/c P.3U1 hypoxanthine, aminopterin, thymidine (HAT)-sensitive cell line (10). 
BALB/c AnN males were immunized with C.AL-20 blast cells. Donor cells were stimulated 
with 5 #g/ml concanavalin A  (Con A)  for  48  h  in complete culture media, harvested, and 
separated on bovine serum albumin (BSA) discontinuous density gradients (5). Cells were 
washed five times in phosphate-buffered saline (PBS),  resuspended, and injected intraperito- 
neally. 
Spleen cells from immunized donors were tested between frosted  glass slides,  erythrocytes 
(RBC)  were  lysed with Tris ammonium chloride, and the cells  were washed  in serum-free 
media. One spleen equivalent was pelleted with 1.2 ×  107 P.3U1 cells in serum-free Dulbecco's 
H-21. Polyethylene glycol (PEG) (Sigma Chemical Co., St. Louis, MO), 1,000 mol wt, in a 30% 
solution (0.5 ml), was added to the drained pellets.  Cells were resuspended and immediately 
repelleted by  1,000 g centrifugation at room temperature. PEG was removed, and  10 ml of 
Dulbecco's H-21 was added slowly over 5 min. Cells were pelleted and resuspended in 60 ml of 
media, used to maintain the P.3U1 parent line, and incubated at 37°C overnight. On day 1, 
1 ×  10  -4 M hypoxanthine, 4 ×  10  -v M aminopterine  and 1.6 ×  10  -5 M thymidine were added, 
and cells were aliquoted into 96-well  microtiter plates (Costar Data Packaging, Cambridge, 
MA). On day 7, cells were fed media containing  HAT. Clones were visible on day 8. The fusion 
frequency was -50% but variable for each fusion. 
Tissue culture supernatant was  screened  for  clones secreting antibody by  a  cell  surface 
radioimmunoassay. Con A was used to activate either BALB/c or C.AL-20 T  cells grown in 
RPMI 1640 with 2% horse serum, not fetal calf serum, which was used in the growth of blast 
cells  for  immunization. Con  A-activated  blast  cells  were  harvested  in  PBS  and  washed 
extensively in serum-free PBS before aliquoting (2 ×  l0  s cells/100 #1) into each well of a 96- 
well polyvinyl chloride tray.  Plates were centrifuged to increase the adherence of cells, and 
supernatant was removed. The plates were placed on ice, and 100/~1 of 0.05% glutaraldehyde 
was  added  for  5 min and followed  by addition of 0.05%  ammonium chloride (100 #1)  and 
washed four times with PBS. Horse serum (2% in PBS) (0.04 M NaNs) was added overnight at 
4°C.  Plates containing either C.AL-20 or BALB/c cells  were  incubated with tissue culture 
supernatants (50 ~./well) for 2 h at room temperature. The plates were washed and incubated 
125  125  0  with 100/~g of  I goat anti-mouse IgGx or  I goat anti-mouse IgM overnight at 4  C. Labeled 
plates were  washed in PBS and separated on a  hot wire cutter for counting. Positive clones 
were selected on the basis of binding  of the antibody to C.AL-20 ceils and not to BALB/c cells. 
Amplification of Antibody-mediated Cell Lysis by Fluorescein Isothiocyanate (FITC)-modified Monoclonal 
Antibody and Mouse Anti-FITC Immunoglobulin.  Monoclonal antibody was  collected from  the 
ascites of mice primed with ~pristane and inoculated with hybrids of P.3U1 and BALB/c AnN 
anti-C.AL-20-immune  cells.  Ammonium sulphate-precipitated protein (10 mg/ml) was mod- 
ified by incubating with 0.5 M sodium carbonate (pH 9.5, containing 10 mg/ml FITC) for  1 
h  at  4°C.  Labeled  protein  was  eluted  from  a  G-25  Sephadex  column in  0.1  M  sodium 
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antibody were incubated with thymoeytes from either C.AL-20 or BALB/c animals for 30 min 
at 37°C. Affinity-purified mouse antibody specific for FITC was incubated with washed cells 
for 30  min  at  37°C  without  NaNs,  and  pelleted cells were  resuspended in  selected rabbit 
complement. After incubating at 45°C for 30 min, cells were resuspended in PBS, pelleted, and 
stored at 4°C, while being scored by eosin red dye exclusion under visual microscopy. FITC 
anti-Tthy  a  was  used  at  0.005  #g/105  cells. This  is  a  20-fold lower concentration  than  the 
unmodified antibody and permitted adsorption by fewer numbers of cells. Data are expressed 
as cytotoxic index. This represents the percent dead cells in samples treated with antibody and 
complement minus the percent dead cells in samples treated with complement divided by the 
percent  dead  cells in  samples treated with  rabbit  anti-brain-associated thymocyte antigen 
(BAT) minus the percent dead cells in samples treated with complement times 100%. 
Adsorption.  Monoclonal  antibody  modified  with  FITC  (0.005  #g)  was  incubated  with 
limiting numbers (1 ×  106 to 1.5 ×  107) of lymphoid cells in an Oudin centrifuge tube (Fisher 
Scientific Co.,  Pittsburgh,  PA)  for  45  min  at  4°C.  Cells  were  centrifuged,  and  clarified 
supernatant was incubated with target cells to evaluate the extent of depletion of antibody. 
BSA Gradient Separation of Thymocyte. The methods used have been described (5). 
Cortisone-resistant Thymocytes.  Adult (8-10 wk) male A/J animals were injected intraperito- 
neally with  2.5  mg  of cortisone phosphate  (Merck,  Sharp  &  Dohme,  West  Point,  PA)  in 
suspension. Animals were killed at 48 h. 
Antigen Priming of Lymph Nodes.  Keyhole limpet hemocyanin (KLH; Calbiochem-Behring 
Corp., San Diego, CA) was modified with picrylsulfonic acid (TBNS). Antigen (50 #g in PBS) 
was emulsified in 50 #1 of complete Freund's adjuvant (CFA; Difco Laboratories, Detroit, MI) 
and injected into footpads of adult animals on days 0 and 7. The draining popliteal nodes were 
removed at day 10 and used as targets for antibody- and complement-mediated lysis. 
Selection of Fetal Thymocyte and Fetal Liver  Hybrids.  Thymocytes were removed microscopically 
from 17-d embryos (pregnancies were timed from the appearance of vaginal plugs). Thymocytes 
(2 X 108 cells/8 embryos) and fetal liver cells (107 cells/8 embryos) were fused with 107 BW5147 
HAT-sensitive tumor cells by incubating in 0.1 ml of 40% PEG (Kochlight Laboratories, Inc., 
Coinbrook, England) for 1 min. Serum-free Dulbeeeo's high glucose minimal essential media 
(Microbiological Associates, Bethesda, MD)  was used to dilute cells to  10 ml over a  10-min 
period. Cells were pelleted gently at 25°C and resuspended in media containing 10% FCS for 
24 h in a  100-ram petri dish. At 24 h, cells were collected by centrifugation and resuspended in 
media containing HAT (1 ×  10  -4 HAT (1 ×  10  ~4 M  hypoxanthine, 1.6 ×  10  -5 M  thymidine, 
and 4 ×  10  -7 M  aminopterine)). Clones (4/150 wells per 8 embryos for thymocytes and 2/500 
wells per 8 embryos for fetal liver) appeared at  14 d  and were screened with antibody and 
complement to see whether they expressed the Thy-l.2, H-2  a, Lyt-l.2, and Lyt-2.2 antigens. 
Lines were used to adsorb anti-Tthy  a, anti-Tind  a, or anti-Tsu  d. 
Selection of Hybrid T Cell Lines Originating  from Antigen-primed Lymph Node Cells.  Lymph nodes 
from C.AL-20 mice secondarily immunized in the footpads with KLH-trinitrophenyl (TNP) in 
CFA were removed and  fused with BW 5147 cells (AKR HAT-sensitive T  cell tumor)  (10). 
Resulting hybrids were scored for surface markers characteristic of the C.AL-20 mice and not  a  the AKR  tumor parent  (Thy-l.2,  Lyt-l.2, Lyt-2.2, H-2 ).  Hybrid lines were  subcloned by 
d  d  d  limiting dilution analysis and screened for expression of Tsu  , Tthy, and Tind  alloantigens. 
The AKR tumor parent, BW5147, is surface negative for these antigens. 
Results 
Tthy a Is expressed on Equal  Numbers of Cortisone-sensitive and Cortisone-resistant Thymo- 
cytes.  The observation (3)  that only 35%  of thymocytes can be lysed by anti-Tthy  d 
and complement suggested this T  cell alloantigen might be a  subpopulation marker 
in  the  thymus.  Monoclonal antibodies specific for Tthy  d  (clone  17IIC6,/~),  Tind  d 
(clone  9IIIA2,  ya,  ~),  and  Tsu d  (clone  13III  B4,  yl,  i¢)  were  modified  with  FITC 
(methods)  and used with  mouse anti-FITC antibodies and complement  to estimate 
the frequency of positive cells in mice treated with 2.5 mg of cortisone phosphate 48 
h  before  surgical  removal  of  the  thymus.  These  values  were  compared  with  the 706  MATURATIONAL  MARKERS  FOR  T  CELLS 
percentages of cells expressing each T cell alloantigen in normal animals evaluated at 
the same time (Table I). Tthy  d is expressed on 25-35% of cells, but anti-Tsu  a or anti- 
Tind  a do not detect any positive cells in the thymus by direct lysis. The frequency of 
Tthyd-positive  cells  is  neither  enhanced  nor  decreased  in  the  cortisone-resistant 
population, which represents 20% of total thymocytes in the A/J animal. This suggests 
that an equal frequency of cells in the cortisone-sensitive and -resistant populations 
are  positive  (25-35%),  although  density of determinants  per  cell  might  limit  the 
accuracy of frequency estimates. Fluorescence experiments (not shown) were unsuc- 
cessful, suggesting the number of surface determinants per cell might be limiting. 
Cortisone-resistant  Thymocytes  Preferentially  Express  Tind a and  Tsu a.  Anti-Tind  d and 
anti-Tsu  d do not lyse thymocytes (Table I). However, adsorption of anti-Tind  a with 
thymocytes depletes the lytic antibody tested on antigen-activated popliteal lymph 
node cells (Fig.  1). The absorption with spleen cells parallels that with thymocytes, in 
contrast to cortisone-resistant thymocytes, which are  10-fold  enriched in adsorbing 
cells  (frame  A).  Anti-Tsu  d could  also  be  adsorbed  by  a  comparable  number  of 
TABLE  I 
Thymocytes Expressing  Tthy a Are Not Restricted to a Subpopulation Defined 
by Cortisone Phosphate Sensitivity 
Cortisone-resistant 
FITC-modified antibody  Control thymocytes  thymocytes 
Tthy  d (17IIC6)  23 ±  1"  15 +  4:~ 
Tsu  d (13IIIB4)  2 ±  1  1 +  1 
Tind  d (9IIIA2)  i  ±  1  1 ±  1 
Thy-l.2  85 ±  5  90 ±  5 
* Cytotoxic index. 
:~ A/J (3-wk-old males, six experimental and six control) were treated with 2.5 
mg cortisone phosphate (i.p.)  48 h  before killing. Thymocytes surviving (2- 
4 X  107 cells/mouse) were 20% of the yield from normal age-matched mice. 
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Fxo.  l.  Thyamocytes from cortisone-treated (C)) or control (0) mice were used to adsorb anti-Tsu  a 
or anti-Tind . Residual antibody was tested on antigen-activated lymph node cells. The ability of 
splenic T  cells to adsorb these antibodies is compared with thymocytes (0). FRANCES L. OWEN  707 
cortisone-resistant thymoeytes (frame B). Therefore, Tsu  d and Tind  d are both prefer- 
entially expressed on the cortisone-resistant population. 
Thy-l.2-sensitive  Cells  in  Bone  Marrow  Express  Tthy a.  Cells  in  the  bone  marrow 
absorb anti-Tthy  d monoclonal antibody with an efficiency 15-25-fold lower than that 
of thymocytes (3).  Pretreatment of the adsorbing cell with anti-Tthy-1.2 monoclonal 
antibody  (11)  and  complement or anti-rabbit  anti-brain-associated  antigen  (BAT) 
(12) antibody and complement depletes an adsorbing cell (Table II). Pretreatment of 
bone marrow cells with complement and adsorption of anti-Tthy  d does remove the 
lytie activity (reduced from C.I.  17 to C.I. 5), showing that complement above does 
not lyse this cell. The use of cytotoxic index to display data corrects for spontaneous 
lysis of thymocytes by complement (5%).  Four experiments showing that both anti- 
BAT and  anti-Thy-l.2 lyse the Tthy-bearing cell in  marrow were done in  double- 
blind experiments. In one experiment, anti-Thy-l.2 alone did not block this adsorp- 
tion. These results might imply that the positive cell in marrow is a recirculating cell 
because prothymocytes are reputed to be Thy-l.2 negative (8). 
BSA  Gradient  Fractionation  of  Tind a-  and  Tsua-bearing  Thymocytes.  Discontinuous 
sedimentation of thymocytes on BSA gradients separates the populations into char- 
acteristic groups (13), which correlates with ability to respond to phytohemagglutinin 
(PHA)  (14).  These groups show differences in the levels of H-2 antigens and Thy-l.2 
per  cell  (15),  and  a  decrease  in  surface  density  might  be  associated  with  more 
"mature" cell populations on the basis of surface characteristics. These characteristic 
bands suggest there are a small number of thymocytes (2%) that are low density cells 
expressing Tsu  d and/or Tind  d but not Tthy  d (Table III). 
Antigen-activated  Lymph  Node  T  Cells  Express  Tind a  and  Tsu a  Antigens  but  Not 
Tthy a.  Monoelonal  antibodies  specific  for  Tthy  d,  Tind  d,  and  Tsu  a  do  not  lyse 
popliteal  lymph  node  cells  from  virgin  mice.  However, secondary  immune  lymph 
node cells from footpad-challenged mice can be lysed with antibody and complement 
(Table IV). The frequency of Tsu  d- or Tindd-expressing cells is not <15% of viable 
cells on day 3 after a secondary immunization with KLH-TNP in CFA. Tthy  d cannot 
be detected on these cells.  When  GFA alone was used to inject  the mice, increased 
frequencies of cells expressing Tind or Tsu could not be detected  (data not shown). 
Although CFA contains mycobacterium, a potential antigen, the quantity of antigen 
might be too low to stimulate T  cells. 
Spleen cells activated with Con A adsorbed antibody nonspecifically to an extent 
that  did  not  permit  examination  of the  expression  of Tsu  d,  Tind  d,  or  Tthy  d  on 
TABLE II 
Bone Marrow Adsorption of Anti-Tthy a Is Dependent on a T Cell That is 
BAT and Thy- 1.2 Surface Positive 
Number  Thymocyte 
adsorbing  Antibody  G'  target cells 
Pretreatment 
adsorbing bone 
marrow cells  cells  cytotoxic index 
--  0  Thy-l.2  +  78 +  1 
--  0  Tthy  d  +  17 + 3 
--  10  7  Tthy  d  +  1 +  1 
Anti-Thy-l.2 + C'  107  Tthy  d  +  21:1:3 
Anti-BAT + C'  10  7  Tthy  d  +  13 -1- 3 
C'  10  7  Tthy  d  +  5 +  t 708  MATURATIONAL MARKERS FOR  T  CELLS 
TABLE  III 
Absorption of Tthy a, Tind  a, and Tsu a by Thyrnocytes Separated on BSA 
Discontinuous Gradients 
Percent BSA-  Cytotoxic index 
separated adsorbing 
cells  Tthy  d  Tind  d  Tsu  d 
None  15 2:2  28 +  5  25 -  5 
23  11 +  1  24±1  16-t-1 
26  >1  10 ±  1  7 +- 3 
29  >1  9±  1  72:2 
35  >1  15 :t: 2  26 +  1 
Unfraetionated  >1  24 +  2  29 +  4 
TABLE  IV 
Enhanced Expression of Tsu a and Tind  a on Antigen-activated T cells 
FITC-modified antibody  Normal lymph  Immune lymph 
node  node* 
Anti-Tind  d (9IIIA2)  1 +  1~:  19 +  2 
Anti-Tthy  d (17IIC6)  1 ~  1  2 "4- 1 
Anti-Tsu  d (13IIIB4)  1 ±  1  12 +  3 
* A/J  (8-wk-old males)  were immunized in the footpad with 50 #g of KLH- 
TNP in CFA (1:1 in PBS) on days -10 and -3. Popliteal nodes from three 
animals were pooled for each group. 
z~ Cytotoxic index on direct visual eytotoxicity experiment. 
mitogen-activated cells. C.AL-20 or BALB/c  cells grown for 96 h  in complete culture 
media  with  5  #g/ml  Con  A  failed  to  express  these  T  cell  alloantigens  in  a  way 
detectable  by  direct  cytotoxicity.  Adsorption  of antibody  with  either  allelic form  of 
antigen  (C.AL-20 or BALB/c)  removes all activity, suggesting Fc-nonspecific adsorp- 
tion has obscured  any results. 
Expression  of  Tsu d,  Tthy d,  and  Tind d  in  the  Homozygous  AKR  "Nude  Streaker"  and 
Heterozygous AKR Littermates.  Because Tthy d is expressed  on a  cell in marrow,  it was 
possible that  a  pre-T cell also expressed  this determinant.  The  nude  animal  is a  rich 
source of pre-T cells. An animal  that  had  the Igh-1 d or Igh-1 e type and  a  nude  gene 
on the same genetic background  was required to complete this experiment.  The AKR 
(Igh-1 d)  animal  has  been  bred  for  expression  of the  nu/nu  streaker  phenotype.  The 
streaker  mutant  genetic  phenotype  arose  as  a  spontaneous  mutation  event  separate 
from  the original  nude  mutation.  The  genetic  trait  is  in  the same  complementation 
group  as  the original nu/nu  gene  (16).  In breeding experiments,  this gene was  shown 
to  be  allelic  with  nude.  The  phenotypic  and  development  characteristics  of  the 
nuStr/nu str animals are currently  inseparable  from those of the nu/nu. 
Bone marrow cells from the AKR  4-/nu  str or nuStr/nu str animal were used  to adsorb 
FITC-modified  anti-Tthy d  monoclonal  antibody  (Fig.  2).  Cells  from  the  thymus  of 
the heterozygous animal (+/nu str) were used as a  positive control. Cells from the nude 
animal (nuStr/nuStr) failed to adsorb anti-Tthy d in contrast to cells from the heterozygote 
(+/nu~tr). These data suggest  that  Tthy a is not a  marker  for pre-T cells present  in the 
nude  animal.  Splenic  cells  from  both  animals  were  also  used  for  adSorption;  both 
were negative (data  not shown). 
Expression  of  Tind d,  Tthy d,  and  Tsu d  Alloantigens  on  Hybrid  T  Cell  Lines  Constructed FRANCES L. OWEN  709 
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FIc. 2.  Bone  marrow cells from AKR nu/nu (D) or littermate heterozygous (nu/+) (m) animals 
were used to adsorb FITC-modified  anti-Thy  d monoclonal antibodies. AKR nu/+ thymocytes,  used 
as adsorbing cells (&), are shown for comparison. Adsorbed antibody was used for eytotoxieity on 
A/J (5 wk) thymocytes.  Unabsorbed antibody (~) was the positive  control. 
between BW5147 and C.AL-20 Antigen-activated  Lymph Node Cells.  Hybrid T  cell lines 
express Tsu  d, Tthy  d, and Tind  d alloantigens (Table V). The lines express these three 
determinants independently, supporing the concept that these antigens are carried on 
separate structural  products,  in contrast  to the possibility that  they might be three 
antigenic sites on the same molecule. The 27 lines typed showed random association 
between Lyt- 1 and Lyt-2 and these antigens. We had reported earlier (2, 5) that Tind  d 
was preferentially associated with  Lyt-l-bearing cells and  that  Tsu  d was associated 
with Lyt-2  + cells. Those determinations were made by adsorbing antibody with virgin 
cell  populations.  The  cells  used  for  fusion  originated  from  the  lymph  node  of 
KLH.TNP CFA secondarily immunized mice. The immune cell populations could be 
vastly different from the virgin, and/or fusion to the tumor cell (BW5147) could result 
in gene inactivation or activation so that an unexpected product is expressed on the 
surface. These data, however, lend little support for a  maturation pathway in which 
Tsu  d- or Tindd-bearing populations parallel the Lyt differentiation schemata. No lines 
coexpress both Tsu  d and Tind  d, suggesting these are distinct and possibly nonoverlap- 
ping lineages.  In contrast,  we found  four  (15%)  lines where Tthy  d was coexpressed 
with either Tsu  d or Tind  d, which  is in  agreement with but  does not prove that  the 
Tthyd-bearing populations  could be precursor populations  for both  the Tind  d- and 
Tsud-bearing cells. It is also possible that double expressing cells could be the result of 
triple cell fusions and not be characteristic cells in the developmental pathway. The 
presence  of multiple  copies  of chromosome  12  per  cell  could  identify  trisomatic 
hybrids. Those karotyping experiments have not been done. The frequency of positive 
cells in any line varied from  10-50% and fluctuated  in response to addition  of new 
culture media. This might indicate that the antigens are expressed with a low surface 
density per cell, and  the unsynchronized  growth  pattern of each line could lead  to 
disparate densities from cell to cell. 
Tthy u,  Tind  a, and Tsu d Appear  Sequentially in Ontogeny.  Thymocytes from neonatal 
mice (1-27 d) were used as targets for direct cytotoxicity with anti-Tthy  d FITC (Fig. 
3,  frame A),  anti-FITC,  and  complement.  Thymocytes from  3-d-old  mice express 
Tthy  d, but  the adult  frequencies of cells are not  detected  until  after day  19.  When 710  MATURATIONAL MARKERS  FOR  T  CELLS 
TABLE  V 
Independent  Expression  of Tthy d,  Tind d, and Tsu d in  T  Cell Hybrids 
Clone  Thy-l.2  Lyt-l.2  Lyt-2.2 
T  cell  phenotype* 
Tthy  d  Tind  a  Tsu  a 
JT,~3  -  -  +  -  +  - 
JTq~4  -  +  -  -  -  + 
JT~6  +  -  +  +  -  - 
JTq~7  -  +  -  -  +  - 
JTq~8  -  +  +  +  -  - 
JT~9~  +  +  +  +  -  + 
JT~ll  +  -  +  -  +  - 
JTOl3  +  ....  + 
JT~14  -  +  -  -  -  + 
JT~I5  -  -  -  +  -  - 
JT~16:I:  -  -  -  +  +  - 
JPD  -  -  +  -  -  + 
JPE:~  +  +  -  +  +  - 
JT~19  -  -  -  +  -  + 
JTq~21  +  +  -  -  -  + 
JTep22  -  -  -  +  -  - 
JT~23  .....  + 
JT~24  -  +  -  +  -  - 
JTqJ26  -  +  +  +  -  - 
JTq~27  -  +  +  -  -  + 
JTq~28  +  -  +  -  +  - 
JTq~30  -  +  +  +  -  - 
JTq~3 l~:  -  +  +  +  -  + 
* Phenotyping was executed with antibody and complement. The percentage 
of positive cells in each hybrid line varied from 10-50% and may result from 
surface antigen density variations in unsynchronized cell populations. 
d  d  d  :~ Four  lines  were  positive  for  both  Tthy  and  Tsu  or  Tind.  This  dual 
expression in JT~9 has been maintained for 9 mo in vitro and appears to be 
a stable characteristic of the cell. 
neonatal  thymocytes  were  used  to  adsorb  anti-Tthy a  and  the  residual  antibody  was 
scored on  adult  thymocytes,  Tthy a  could  be  detected  on  days  1-2  (Fig.  3,  frame  B). 
It is possible that  Tthy a  is expressed on fetal thymocytes  as a  surface determinant  but 
our assay is too insensitive to detect  these determinants.  One  might  predict  a  gradual 
increase in surface density  as  the positive cells  appear  in ontogeny.  There  is a  linear 
increase in the percentage  of positive cells between  day  2  and  day  5  (Fig.  3, frame  A). 
Extrapolating  that  line  back  to  the origin would  suggest the  frequency  in  fetal  cells 
should  be <0.1%.  It seemed  of interest to look for surface expression of Tthy a on fetal 
thymocytes  because  functional  studies by Ceredig  et  al.  (17)  have  shown  that  day  14 
fetal  cells  have  antigen  receptors  for  histocompatibility  antigens.  To  overcome  the 
problems  of low  yields  of fetal  cells  from  dissection,  coupled  with  an  expected, low 
frequency  of positive  cells,  hybrid  T  cell  lines  were  constructed  by  fusing  BW5147 
HAT-sensitive  cells  with  17-d  fetal  thymocytes  (Table  VI).  Three  lines  were  estab- 
lished,  all  of which  failed  to  adsorb  these  antigens.  Statistcally,  one  would  have  to 
examine  10,000 lines, if the frequency  of positive cells is 0.1%, to conclude  that  day-17 
thymocytes  do  not  express Tthy a  as  a  surface antigen.  It  is,  however,  apparent  that 
some fetal cells that express Thy- 1.2 do not express Tthy d. Two  fetal T  lines originating FRANCES  L.  OWEN 
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Flo.  3.  Ontogeny of surface  expression  of Tthy  d detected  by  direct  cytotoxicity  on  neonatal 
th~mocytes or adsorption of antibody onto neonatal thymocytes. Cells from neonatal thymus (5 X 
10  cells/microtiter well)  were  incubated with  10 ~tl  of tissue  culture  supernatant containing 
monoclonal anti-Tthy  d modified with FITC. Percent dead cells was enumerated after an incubation 
with complement (frame A). In contrast, 5 ×  l0  n neonatal thymocytes were used to adsorb 40/d of 
d  monoclonal anti-Tthy  (frame  B).  Residual  antibody was  scored  by  cytotoxicity  on  4-wk-old 
thymocytes. 
TABLE VI 
Tthy a,  Tind  a, and Tsu a Are Not Expressed on Day-17 Fetal T  Cell Hybrids 
Clone  Thy-l.2  Lyt-l.2  Lyt-2.2  Tthy  d  Tind  d  Tsu  d 
FTT 17-1  +  ..... 
FTT 17-2  +  ..... 
FTT 17-3  +  +  .... 
FTL 17-1  +  ..... 
FTL 17-2  ...... 
* Surface  phenotyping was  done with  antibody and complement. All are 
surface immunoglobulin  negative. 
from  fusion of BW5147 with  fetal  liver cells are reported  in Table VI.  It  is possible 
that  these  cells  are  precursor  T  cells  because  one  line expresses  Thy-l.2  with  high 
densities at all times in the cell cycle, one is negative for Thy-1.2, but both fail to have 
detectable levels of Lyt- 1 and Lyt-2. However, the ability to express Lyt- 1 and Lyt-2 
could be dependent, either directly or indirectly, upon the expression of chromosomes 
that  are  lost in these  hybrid lines. All the fetal  lines experienced  4-wk crisis periods 
early in establishment. Similarly, only one of the three lines that originated from fetal 
thymus fusion with BW5147 expressed  Lyt-l.2.  Because Thy-l.2  and  Lyt-l.2 should 
be expressed on fetal thymocytes at  17 d, it is unclear why our hybrids do not display 
these  antigens.  This  might  be  a  result  of the  statistical  frequency  of positive  cells, 
BW5147 might have a  preferential fusion partner, or Lyt-l.2 might be on a  chromo- 712  MATURATIONAL MARKERS FOR  T  CELLS 
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Fro. 4.  Ontogeny  of surface expression of Tsu a and Tind  a. In frame A, monoclonal  anti-Tsu  a 
(0.005 #g), FITC modified, was adsorbed with 5 ×  106 spleen cells. Residual antibody was tested by 
direct cytotoxicity on antigen-primed  lymph node cells. In frame B, 0.05 #g of monoclonal anti- 
Tindd-FITC in 40 #1 was absorbed with 5 x  108 unfractionated  spleen cells. Residual antibody was 
incubated with KLH-TNP-primed lymph node cells. Previous experiments determined the optimum 
number of adsorbing cells and the best concentration of antibody. 
some that segregates and is easily lost. 
Tind  a  is expressed on  neonatal  splenic cells at  days 2-3  (Fig. 4,  frame A). Anti- 
Tind  a can be adsorbed by 5  x  10  6 neonatal spleen cells, and the lytic activity of that 
antibody  on  antigen-activated  popliteal  node  cells  is  depleted  by  day-2  cells.  In 
contrast, anti-Tsu  a could not be adsorbed by splenic T  cells (5 ×  10 6)  until days 5-6 
postnatally (Fig. 4, frame B). 
Discussion 
If multiple  isotypes of T  cell  receptors  exist  (1),  then  the  expression  of distinct 
isotypes might  be  characteristic of the  maturational  level  of the  cell  and  not  the 
functional subpopulation  (18).  B  lymphocytes have been shown  to undergo a  differ- 
entiation  pathway  from  IgM  ---* IgM  +  IgD  --~  IgD  or  IgG  (19)  in  response  to 
antigenic pressures. It is possible that T  cells undergo a  similar pathway in which a 
primitive receptor-bearing cell  is  the  precursor  (pre-T)  for  all T  cells. As  that  cell 
matures ontogenetically and functionally, it might acquire new isotypes that make it FRANCES L. OWEN  713 
functionally more efficient (20). 
Fetal  thymocytes express receptors for alloantigens.  At  day  14 of gestation, thy- 
mocyte precursors for CTL- or MLR-alloreactive cells exist, and these cells can mature 
functionally in organ cultures (21, 22).  These are the earliest known T  cell functions 
(6). Because alloreactivity parallels the development of the thymic rudiment (23) and 
the earliest expression of Thy-l.2  (24), the antigen  receptor on alloreactive T  cells 
could be considered the primitive T  cell ~  analogue.  In contrast to these data,  we 
found that Tthy  d, Tind  d and Tsu  d, all of which are expressed postnatally, are markers 
on  late-maturing  cells.  It  is,  therefore, not  surprising  that  monoclonal  antibodies 
specific  for  Tthy,  Tsu,  and  Tind  do  not  react  with  cytotoxic  effector cells  for 
alloantigens  or  precursors  of MLR-reactive cells.  (G.  M.  Spurll,  L.  Riendeau,  A. 
Finnegan, and F. L. Owen, manuscript in preparation). 
Congenitally athymic mice (BALB/e nu/nu) have pre-T cells that can be induced 
to  mature  to  functional cytotoxic T  cells  in  the  presence of T  cell  growth  factor 
(TCGF)  (9).  One would expect that they have antigen receptors and, therefore, the 
presence of a thymus is not a prerequisite for expressiOn of antigen receptors. Because 
the Tthy  d alloantigen is expressed preferentially on thymocytes and marrow cells and 
lost  on  functionally mature  T  cells,  it  seemed a  likely candidate  for a  pre-T cell 
antigen receptor. This is not the case; adsorption studies with marrow and spleen cells 
show that  the AKR nu/nu streaker does not have the Thyd-bearing cell population. 
The data showing that the marrow cell bearing Tthy  d is a Thy-l.2, BAT-positive cell 
also suggest that this cell is a  more mature recirculating T  cell and not a  pre-T cell 
(8).  In addition, experiments depleting Tthy  d by in vivo injection at birth with #g 
quantities of monoclonal anti-Thy  d do not produce a T-cell-depleted mouse, although 
Tthy  d-, Tsu  d- and Tind-bearing cells do not develop (S.  K. Keese and F.  L. Owen, 
manuscript in preparation). Other immunization protocols have been initiated to look 
for a  pre-T cell  receptor coded  for by a  gene  linked  to  Tsu,  Tind,  and  Tthy on 
chromosome 12. One would predict that a fetal T  cell should express that isotype by 
day  15 in gestation and that the precursor for the cytotoxic T  cell in nude animals 
might retain that isotype. 
That T cell receptor isotypes are characteristic of functionally diverse cells has been 
hypothesized (1,  25). This speculation is based on experimental data showing that 
Tsu and Tind are preferentially expressed on either Lyt-2 or Lyt-1 cells (1, 2) and on 
the finding that  antisera made with a  similar  immunization protocol distinguishes 
between antigen:specific augmenting and suppressing factors (26). Contrasting data 
from the studies of Binz and Wigzell (27) show that alloreactive antigen receptors on 
Lyt-1- and Lyt-2-bearing cells are identical. These data are compatible when func- 
tional diversification occurs before receptor isotype acquisition. It is possible that the 
T  cell lineage is branched; a pre-T cell could mature into a cytotoxic precursor (Tpc) 
and, from that line, a  group of regulatory cells (Ts, Th, Tind) could diverge. If Ts, 
Tc,  Th  develop  in  ontogeny much  later  than  To,  the  receptor  isotypes could  be 
acquired after Lyt-1- and Lyt-2-bearing cells functionally diversify (28). The isotypes 
of the late-maturing population would appear to be distinctive of the Lyt functional 
type, whereas an early maturing alloreactive cell would use the same isotypes for Lyt- 
1 or  Lyt-2 cells.  If one  isotype  is  more  efficient  for  a  particular  functional  cell, 
antigenic pressures would expand the most appropriate clone. One would expect to 
see T  suppressor cells with a  spectrum of isotypes, one of which might predominate 714  MATURATIONAL MARKERS FOR T  CELLS 
because these clones have been selectively expanded. In nature, one might expect to 
see  most  suppressor  receptors associated  with  the  Tsu  isotype, whereas  individual 
clones, some of which would be functionally more competent, would have random 
isotypes. 
The latter interpretation fits the data obtained with our T  cell hybrids. In the 27 
clones examined, cells express either Tsu  or Tind.  No  clone showed simultaneous 
expression of both antigens, although 3 of 27 clones showed Tthy  d co-expressed with 
Tsu or Tind. These data are consistent with our initial observations that Tsu-bearing 
cells  and  Tind  cells  represent  two  separate  lineages  of cells  and  that  the  Tthy 
population  may be  a  precursor  for both  these  cells.  Tsu  and  Tind  show  random 
association with  Lyt-1 or Lyt-2 in  the hybrids.  No functional data  is available for 
these clones. It is possible that association of an appropriate T  cell isotype with an 
appropriate I-A or I-J phenotype is necessary for function (29-30). I region-encoded 
products may contribute to the quaternary structure of these polypeptides. If this is 
the  case,  many  of our  hybrids  may  be  nonfunctional;  only a  clone  that  has  the 
appropriate random association of Tind, I-A, and/or Lyt-1 chains would be biologi- 
cally functional. This model necessitates waste of many precursor clones that might 
have the appropriate variable region specificity but does account for the observed Ia- 
associated restrictions on T  cell factors. 
Some of our "T cell" hybrids (Table V) do not express Tthy-1.2. It is possible that 
segregation of chromosomes takes  place,  independently leading to loss  of Thy-l.2, 
Lyt-1.2, and Lyt-2.2. These clones were selected for expression of Tsu, Tind, or Tthy. 
None express surface immunoglobulin. Mature T cells are frequently low theta dense, 
and  the hybrids might  have few alloantigens per cell, escaping detection by direct 
lysis. The surface expression ofTsu, Tind, and Tthy is a stable phenotype; chromosome 
12 may be vital for growth of the cell and, therefore, would not be deleted in viable 
cells. 
The maturational schemata for T  cells (Fig. 5)  illustrates the acquisition of Tthy, 
Tind, or Tsu at characteristic points in development. Many thymocytes express Tthy  d 
(35% C.I.), although it is a subpopulation marker. Studies of Keese and Owen show 
that this is not a determinant on all cells in the thymus. Both cortisone-sensitive and 
-resistant  cells express Tthy  d,  although  a  low density thymocyte, which  is Thy-l.2 
sparse and H-2k dense, lacks this antigen. Cortisone-resistant thymocytes, in contrast, 
express Tind and Tsu. Tsu is preferentially expressed on thymocytes in the least dense 
BSA fraction. As  cells exit th  e  thymus, Tthy is  lost.  We know it  must  be present 
genetically in some of the cells in the periphery because our hybrids, which originate 
from lymph node, rescue this specificity. This might be due to genetic complemen- 
tation, assuming Tthy  d is not deleted, and Tthy  d need not be assumed to be a surface 
marker in lymph node in vivo for the results to be consistent. Resting spleen cells can 
adsorb Tsu and Tind but the frequency of cells and/or density of antigen per cell 
prevents visualization of direct  killing.  In  contrast,  15-20%  of popliteal  node cells 
from antigen-primed, footpad challenged mice express Tind or Tsu. The populations 
appear to be numerically nonoverlapping. Tthy-, Tind-, and Tsu-bearing populations 
might  represent  a  progression  of cells  undergoing  differentiation pressures,  which 
parallel acquisition of immunocompetence. 
B  lymphocytes express surface  isotypes  after antigenic  maturation  in  a  prepro- 
grammed order that follows the order of the constant region genes on chromosome 12 S
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(~ ?~ y~ ~'1 y2b 72a a  E)  (31).  That same order is followed in the ontological expression 
of the  isotypes  (7).  It  is  possible  that  variable  region  genes  must  be  translocated 
sequentially by inserting into characteristic switch sites rather than being randomly 
translocated to a constant region gene downstream from/~. The order of expression of 
Tthy  d, Tind  d, and Tsu  a on maturing T  cells (not proven to be antigen triggered) also 
parallels the ontological order of appearance of these antigens. This suggests a similar 
organization of genes within a  T  cell-receptor gene complex. Because cDNA probes 
do not yet exist for T  cell-constant regions, one can only speculate that a mechanism 
for biological preservation of VH genes could dictate the use of characteristic switch 
mechanism for T  cell antigen receptors. 
Summary 
Monoclonal  antibodies  specific for three T  cell alloantigens  linked  to the  immu- 
noglobulin complex on chromosome 12 were used to establish the order of expression 
of  these  antigens  on  immunocompetent  cells  and  in  ontogeny.  Modification  of 
monoclonal  antibodies  with  fluorescein  isothiocyanate  (FITC)  and  use  with  anti- 
FITC and complement has amplified lytic capacity of the monoclonals and allowed 
us  to  complete  a  distribution  study  of Tsu  a,  Tind  d,  and  Tthy  d  alloantigens  on 
immunocompetent cells. Tthy  d is expressed on both cortisone-sensitive and cortisone- 
resistant thymocytes; Tsu  d and Tind  d are on "mature" cortisone-resistant cells. Tthy  d 
is also expressed on a Thy-l.2-bearing recirculating marrow cell but is undetectable 
in  the  peripheral  T  cell  pool.  In  contrast,  resting  spleen  and  lymph  node  T  cells 
express Tsu  d and Tindd; antigen-activated populations express these two cells in high 
frequencies. These antigens must be markers for relatively differentiated cells because 
"nude" animals, which have pre-T cells, fail to express these determinants.  All three 
antigens segregate independently in our T  cell hybrids, arising from adult peripheral 
node cells, supporting the hypothesis that these are three separate structural products 
of a gene complex. In contrast, fetal T  cell hybrids fail to express these antigens. The 
appearance of all three antigens on the cell surface in ontogeny is postnatal; Tthy  d is 
expressed at days 1-2, Tind  d at days 2-3, and Tsu  d at days 5-6. If the T  cell isotype 
genes are organized similar to the immunoglobulin loci, then the parallels in matu- 
rational  expression on  immunocompetent cells and  in  ontogeny would  lead one to 
speculate a  gene order of Tthy  d ~  Tind  d --> Tsu  d.  Orientation  with  respect to the 
centromere is unknown. 
The technical assistance of John Fontana and Lauren Riendeau is appreciated. 
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